图书简介
Cancer affecting the gastrointestinal tract is the most common of all human malignancies, occurring in patients worldwide. Recent clinical advances in the management of GI cancer have relied upon collaborative interactions between a wide variety of specialists including: surgical, radiation, and medical oncologists; gastroenterologists; radiologists; and pathologists. In 74 chapters, Gastrointestinal Oncology brings together a diverse group of specialists to provide the most authoritative, up-to-date and encyclopedic volume currently available on the subject.
Part I - General Principles; 1: Amos & Spitz: Epidemiological Principles for the Study of Gastrointestinal Cancers; 2: Shureiqi, Reddy, Ruffin & Brenner: Prevention and Screening Principles Relevant to Gastrointestinal Malignancies; 3: Lynch: The Role of Inheritance in the Diagnosis and Management of Gastrointestinal Malignancies; 4: Babyatksy: Developmental Biology of the Gastrointestinal Tract; 5: Fenoglio-Presier: General Pathobiological Features of Gastrointestinal Neoplasia; 6: Smith & Evans: Theraputic Principles of Gastrointestinal Neoplasia: Surgery; 7: Spiro & Willett: Theraputic Principles of Gastrointestinal Neoplasia: Radiation Oncology; 8: Xiong & Abbruzzese: Therapeutic Principles of Gastrointestinal Neoplasia: Emerging Therapies: Vaccines; 9: Jessup: Therapeutic Principles of Gastrointestinal Neoplasia: Emerging Therapies: Vaccines; 10: Aspinall & Lemoine: Therapeutic Principles of Gastrointestinal Neoplasia: Emerging Therapies: Gene Therapy; 11: Hoff, Abbruzzese & Pluda: Therapeutic Principles of Gastrointestinal Neoplasia: Emerging Therapies: Antiangiogenic and Antimetastatic Agents; Part II - Management of Specific Neoplasms; Cancer of the Esophagus; 12: Lord & Danenberg: Epidemiology and Molecular Epidemiology of Esophageal Cancer; 13: Tselepis & Janikowski: Molecular Biology of Esophageal Cancer; 14: Glickman & Odze: Pathology and Natural History of Esophageal Cancer; 15: Krasna & Jiao: Clinical Aspects and Management of Esophageal Carcinoma: Diagnostic and Staging Procedures; 16: Putnam: Clinical Aspects and Management of Esophageal Carcinoma: Management Options: Potentially Resectable Esophageal Cancer; 17: Small, Talamonti & Benson: Clinical Aspects and Management of Esophageal Carcinoma: Management Options: Locally Advanced Unresectable Esophageal Cancer; 18: Ajani & Blumenschein: Clinical Aspects and Management of Esophageal Carcinoma: Management Options: Therapy of Metastatic Carcinoma of the Esophagus and Gastroesophageal Junction; 19: Paulson & Reid: Barrett’s Esophagus: Molecular Biology and Pathobiology; 20: Spechler: Barrett’s Esophagus: Clinical Aspects and Management; Cancer of the Stomach; 21: Moss & Shirin: Epidemiology and Molecular Epidemiology of Gastric Cancer; 22: Tahara: Molecular Biology of Gastric Cancer; 23: Fenoglio-Preiser, Amy Noffsinger & Stemmermann: Pathology and Natural History of Gastric Cancer; 24: Waxman & Parmar: Clinical Aspects and Management of Gastric Carcinoma: Diagnostic and Staging Procedures; 25: Mansfield: Clinical Aspects and Management of Gastric Carcinoma: Management Options: Potentially Resectable Gastric Cancer; 26: Clark: Locally Advanced Unresectable Gastric Cancer; 27: Kulke & Mayer: Management Options: Metastatic Gastric Carcinoma; Cancer of the Pancreas; 28: Li: Epidemiology and Molecular Epidemiology of Pancreatic Cancer; 29: Jean, Lowy, Evans & Chiao: Molecular Biology of Pancreatic Adenocarcinoma; 30: Mutema & Fenoglio-Presier: Pathology and Natural History of Pancreatic Cancer; 31: Charnsangavej & Lahoti: Clinical Aspects and Management of Pancreatic Adenocarcinoma: Diagnostic and Staging Procedures; 32: Abdalla, Pisters & Evans: Clinical Aspects and Management of Pancreatic Adenocarcnoma: Management Options: Potentially Resectable Pancreatic Cancer; 33: Tempero, Termuhlen, Brand & McGinn: Clinical Aspects and Management of Pancreatic Adenocarcinoma: Management Options: Locally Advanced Unresectable Pancreatic Cancer; 34: Rothenberg & Berlin: Clinical Aspects and Management of Metastatic Pancreatic Cancer; Cancer of the Bile Ducts and Gallbladder; 35: Soloway & Rego: Epidemiology, Molecular Epidemiology and Biomarkers of Biliary Tract Cancers; 36: Goggins: Molecular Biology of Cholangiocarcinoma and Gallbladder Carcinoma; 37: Rashid: Pathology and Natural History of Cholangiocarcinoma and Gallbladder Carcinoma; 38: Raijman: Clinical Aspects and Managment of Cholangiocarcinoma and Gallbladder Carcinoma: Diagnostic and Staging Procedures; 39: Curley: Clinical Aspects and Management of Cholangiocarcinoma and Gallbladder Carcinoma: Potentially Resectable Gallbladder Carcinoma or Cholangiocarcinoma; 40: Roh & Johnnides: Clinical Aspects and Management of Cholangiocarcinoma and Gallbladder Carcinoma: Unresectable Gallbladder Carcinoma and Cholangiocarcinoma: Management Options; Hepatocellular Cancer; 41: Hassan & Patt: Epidemiology and Molecular Epidemiology of Hepatocellular Cancer; 42: Grisham: Molecular Biology of Hepatocellular Cancer; 43: Balis & Lauwers: Pathology and Natural History of Hepatocellular Carcinoma; 44: Choti: Clinical Aspects and Management of Hepatocellular Cancer: Management Options: Potentially Resectable Hepatocellular Cancer: Diagnostic and Staging Procedures; 45: Roh & Robke: Clinical Aspects and Management of Hepatocellular Cancer: Management Options: Potentially Resectable Hepatocellular Carcinoma; 46: Patt & Hassan: Clinical Aspects and Management of Hepatocellular Cancer: Management Options: Metastatic Hepatocellular Carcinoma; Cancer of the Small Bowel and Appendix; 47: Neugut & Arber: Epidemiology, Molecular Epidemiology, and Molecular Biology of Small Bowel and Appendiceal Adenocarcinomas; 48: Carr & Sobin: Pathology and Natural History of Small Bowel and Appendiceal Cancers; 49: Horton & Fishman: Clinical Aspects and Management of Small Bowel and Appendiceal Cancers: Diagnostic and Staging Procedures; 50: Temple & Coit: Clinical Aspects and Management of Small Bowel and Appendiceal Cancers: Management Options: Potentially Resectable Small Bowel or Appendiceal Carcinomas; 51: Kulke & Fuchs: Clinical Aspects and Managment of Small Bowel and Appendiceal Cancers: Management Options: Unresectable, Locally Advanced and Metastatic Small Bowel and Appendiceal Carcinomas; Cancer of the Colorectum; 52: Hawk, Viner & Limberg: Epidemiology and Prevention of Colorectal Cancer; 53: Su: Molecular Biology of Colorectal Cancer; 54: Smyrk & Lynch: Familial Colorectal Cancer Syndromes; 55: Stemmermann & Fenoglio-Preiser: Pathology and Natural History of Colorectal Cancer; 56: Cima & Bleday: Clinical Aspects and Management of Colon Adenocarcinoma: Diagnostic and Staging Procedures; 57: Guillem & Saltz: Clinical Aspects and Management of Colon Adenocarcinoma: Management Options: Management of Local and Local-Regional Colon Cancer; 58: Lahoti: Clinical Aspects and Management of Rectal Adenocarcinoma: Diagnostic and Staging Prodecures; 59: Porter & Skibber: Clinical Aspects and Management of Rectal Adenocarcinoma: Management Options: Resectable Rectal Carcinoma; 60: Minsky: Clinical Aspects and Management of Rectal Adenocarcinoma: Management Options: Unresectable Rectal Carcinoma; 61: Vauthey, Medgyesy, Gofin, Royce, Ayoub & Hoff: Management Options: Metastatic Colorectal Carcinoma; Cancer of the Anus; 62: Agoff & Kiviat: Pathology, Molecular Biology, and Natural History of Anal Cancer; 63: Gaspar, Mertens, Raben & Evans: Clinical Aspects and Management of Anal Cancer; Neuroendocrine Cancers of the Gastrointestinal Tract; 64: Yao & Ajani: Management of Neuroendocrine Cancers of the Gastrointestinal Tract: Carcinoid Tumors; 65: Hoff, Cote & Gagel: Management of Neuroendocrine Cancers of the GI Tract: Islet Cell Carcinoma of the Pancreas and Other Neuroendocrine Carcinomas; Lymphomas of the Gastrointestinal Tract; 66: Sepulveda: Mucosa-Associated Lymphoid Tissue Lymphomas; 67: Cabanillas & Pro: Low-and-High-Grade Lymphomas; Sarcomas of the Gastrointestinal Tract; 68: Bilimoria, Berman & Pollock: Epidemiology, Pathology, Molecular Biology, and Natural History of Gastrointestinal Sarcomas; 69: Cormier & Pisters: Clinical Aspects and Management of Gastrointestinal Sarcomas: Management Options: Potentially Resectable Gastrointestinal Sarcomas; 70: Patel & Benjamin: Clinical Aspects and Management of Gastrointestinal Sarcomas: Management Options: Unresectable or Metastatic Gastrointestinal Sarcomas; Part III - Palliative Care of Patients with Gastrointestinal Malignancy; 71: Strasser & Bruera: Nutritional Support of Patients with Gastrointestinal Malignancies; 72: Giap & Chang: Management of Obstructive Complications: Upper Gastrointestinal Tract: Esophagus, Stomach, and Biliary Tree; 73: Al-Antably & Lahoti: Management of Obstructive Complications of Lower Gastrointestinal Tract: Colon and Rectum; 74: Elsayem & Bruera: Pain Management
Trade Policy 买家须知
- 关于产品:
- ● 正版保障:本网站隶属于中国国际图书贸易集团公司,确保所有图书都是100%正版。
- ● 环保纸张:进口图书大多使用的都是环保轻型张,颜色偏黄,重量比较轻。
- ● 毛边版:即书翻页的地方,故意做成了参差不齐的样子,一般为精装版,更具收藏价值。
关于退换货:
- 由于预订产品的特殊性,采购订单正式发订后,买方不得无故取消全部或部分产品的订购。
- 由于进口图书的特殊性,发生以下情况的,请直接拒收货物,由快递返回:
- ● 外包装破损/发错货/少发货/图书外观破损/图书配件不全(例如:光盘等)
并请在工作日通过电话400-008-1110联系我们。
- 签收后,如发生以下情况,请在签收后的5个工作日内联系客服办理退换货:
- ● 缺页/错页/错印/脱线
关于发货时间:
- 一般情况下:
- ●【现货】 下单后48小时内由北京(库房)发出快递。
- ●【预订】【预售】下单后国外发货,到货时间预计5-8周左右,店铺默认中通快递,如需顺丰快递邮费到付。
- ● 需要开具发票的客户,发货时间可能在上述基础上再延后1-2个工作日(紧急发票需求,请联系010-68433105/3213);
- ● 如遇其他特殊原因,对发货时间有影响的,我们会第一时间在网站公告,敬请留意。
关于到货时间:
- 由于进口图书入境入库后,都是委托第三方快递发货,所以我们只能保证在规定时间内发出,但无法为您保证确切的到货时间。
- ● 主要城市一般2-4天
- ● 偏远地区一般4-7天
关于接听咨询电话的时间:
- 010-68433105/3213正常接听咨询电话的时间为:周一至周五上午8:30~下午5:00,周六、日及法定节假日休息,将无法接听来电,敬请谅解。
- 其它时间您也可以通过邮件联系我们:customer@readgo.cn,工作日会优先处理。
关于快递:
- ● 已付款订单:主要由中通、宅急送负责派送,订单进度查询请拨打010-68433105/3213。
本书暂无推荐
本书暂无推荐